Ansulong, Manilyn A.
HRN: 27-93-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFUROXIME 1.5GM (VIAL)
10/15/2025
10/22/2025
IVT
1.5 Gms
Q 8
CAP MR
Checking Initial Appropriateness
Indication: Empiric Type of Infection: PneumoniaReproductive Tract Compliance to guidelines: Compliant To Guidelines